Use of Bicycle Exercise Echocardiography for Unexplained Exertional Dyspnea
Shalabh Singhal(Integrated BioTherapeutics (United States)), Yukitaka Shizukuda(University of Cincinnati), Neal L. Weintraub(Augusta University), Mian Atif Yousuf(University of Cincinnati)
Cited by 6
Related Papers
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase <scp>II</scp>, Randomized, <scp>Double‐Blind</scp>, <scp>Placebo‐Controlled</scp> Trial
|Arthritis & Rheumatology|2022|261
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
|Annals of the Rheumatic Diseases|2022|212
Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis
|European Heart Journal|2021|156
Risk of Major Bleeding with Concomitant Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients Receiving Long‐Term Warfarin Therapy
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2007|93